Russell Investments Group
CAPR icon

Russell Investments Group’s Capricor Therapeutics CAPR Stock Holding History

Russell Investments Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
14,290
+9,709
+212% +$294K ﹤0.01% 2957
2026
Q1 		$139K Sell
4,581
-59
-1% -$1.57K ﹤0.01% 2976
2025
Q4 		$134K Sell
4,640
-426
-8% -$5.56K ﹤0.01% 2957
2025
Q3 		$36.5K Buy
5,066
+2,786
+122% +$20.5K ﹤0.01% 3396
2025
Q2 		$22.6K Buy
2,280
+179
+9% +$1.89K ﹤0.01% 3163
2025
Q1 		$19.9K Sell
2,101
-2,551
-55% -$35.4K ﹤0.01% 3109
2024
Q4 		$64.2K Buy
4,652
+2,947
+173% +$51.6K ﹤0.01% 2770
2024
Q3 		$25.9K Buy
+1,705
New +$8.43K ﹤0.01% 2907

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's CAPR Position: Q2 2026 in Review

Russell Investments Group increased its Capricor Therapeutics (CAPR) stake by 212% in Q2 2026, buying an estimated $294K and bringing the position to 14,290 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

Russell Investments Group first reported a position in CAPR in Q3 2024 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Russell Investments Group held 14,290 shares of Capricor Therapeutics worth $344K as of Q2 2026.
  • Russell Investments Group bought 9,709 Capricor Therapeutics shares in Q2 2026, an estimated $294K.
  • Capricor Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2957 holding.
  • Russell Investments Group first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 65 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.